For instance, fatty acid metabolism is engaged in melanoma and ovarian tumors, so these tumors could benefit from the inhibition of the fatty acid transport proteins SLC27A1 (also called FATP1) and CD36, respectively [12, 31, 199]. This evidence concerns the gene SLC27A1 and ovarian neoplasm.